The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis (Q29542112)
Jump to navigation
Jump to search
scientific article (publication date: May 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis |
scientific article (publication date: May 2003) |
Statements
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis (English)
1 reference
T.H McGlashan
1 reference
22 April 2017
R.B Zipursky
1 reference
D Perkins
1 reference
J Addington
1 reference
T.J Miller
1 reference
S.W Woods
1 reference
K.A Hawkins
1 reference
R Hoffman
1 reference
S Lindborg
1 reference
M Tohen
1 reference
A Breier
1 reference
May 2003
1 reference
61
1 reference
1
1 reference
7-18
1 reference